Global and China Hospital-acquired Infection Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Instrument and Reagents
  • 1.2.3 Consumables
• 1.3 Market by Application
  • 1.3.1 Global Hospital-acquired Infection Diagnostics Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Clinics
  • 1.3.4 Ambulatory Surgery Centers (ASC)
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Hospital-acquired Infection Diagnostics Market Perspective (2015-2026)
• 2.2 Global Hospital-acquired Infection Diagnostics Growth Trends by Regions
  • 2.2.1 Hospital-acquired Infection Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Hospital-acquired Infection Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Hospital-acquired Infection Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Hospital-acquired Infection Diagnostics Players by Market Size
  • 3.1.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Players (2015-2020)
• 3.2 Global Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Hospital-acquired Infection Diagnostics Revenue
• 3.4 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio
  • 3.4.1 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired Infection Diagnostics Revenue in 2019
• 3.5 Key Players Hospital-acquired Infection Diagnostics Area Served
• 3.6 Key Players Hospital-acquired Infection Diagnostics Product Solution and Service
• 3.7 Date of Enter into Hospital-acquired Infection Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-acquired Infection Diagnostics Breakdown Data by Type (2015-2026)

• 4.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Type (2021-2026)

5 Hospital-acquired Infection Diagnostics Breakdown Data by Application (2015-2026)

• 5.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Application (2015-2020)
• 5.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Hospital-acquired Infection Diagnostics Market Size (2015-2026)
• 6.2 North America Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
• 6.3 North America Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
• 6.4 North America Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Hospital-acquired Infection Diagnostics Market Size (2015-2026)
• 7.2 Europe Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
• 7.3 Europe Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
• 7.4 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Hospital-acquired Infection Diagnostics Market Size (2015-2026)
• 8.2 China Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
• 8.3 China Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
• 8.4 China Hospital-acquired Infection Diagnostics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Hospital-acquired Infection Diagnostics Market Size (2015-2026)
• 9.2 Japan Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
• 9.3 Japan Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
• 9.4 Japan Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Hospital-acquired Infection Diagnostics Market Size (2015-2026)
• 10.2 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Introduction
  • 11.1.4 Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020))
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 Advan DX
  • 11.2.1 Advan DX Company Details
  • 11.2.2 Advan DX Business Overview
  • 11.2.3 Advan DX Hospital-acquired Infection Diagnostics Introduction
  • 11.2.4 Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.2.5 Advan DX Recent Development
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Abbott Business Overview
  • 11.3.3 Abbott Hospital-acquired Infection Diagnostics Introduction
  • 11.3.4 Abbott Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.3.5 Abbott Recent Development
• 11.4 Astrazeneca PLC
  • 11.4.1 Astrazeneca PLC Company Details
  • 11.4.2 Astrazeneca PLC Business Overview
  • 11.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Introduction
  • 11.4.4 Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.4.5 Astrazeneca PLC Recent Development
• 11.5 Bayer Schering Pharma LLC
  • 11.5.1 Bayer Schering Pharma LLC Company Details
  • 11.5.2 Bayer Schering Pharma LLC Business Overview
  • 11.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Introduction
  • 11.5.4 Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.5.5 Bayer Schering Pharma LLC Recent Development
• 11.6 Becton Dickinson And Company
  • 11.6.1 Becton Dickinson And Company Company Details
  • 11.6.2 Becton Dickinson And Company Business Overview
  • 11.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Introduction
  • 11.6.4 Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.6.5 Becton Dickinson And Company Recent Development
• 11.7 Cepheid Inc.
  • 11.7.1 Cepheid Inc. Company Details
  • 11.7.2 Cepheid Inc. Business Overview
  • 11.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Introduction
  • 11.7.4 Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.7.5 Cepheid Inc. Recent Development
• 11.8 Roche AG
  • 11.8.1 Roche AG Company Details
  • 11.8.2 Roche AG Business Overview
  • 11.8.3 Roche AG Hospital-acquired Infection Diagnostics Introduction
  • 11.8.4 Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.8.5 Roche AG Recent Development
• 11.9 Daiichi Sankyo
  • 11.9.1 Daiichi Sankyo Company Details
  • 11.9.2 Daiichi Sankyo Business Overview
  • 11.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Introduction
  • 11.9.4 Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.9.5 Daiichi Sankyo Recent Development
• 11.10 Hologic, Inc.
  • 11.10.1 Hologic, Inc. Company Details
  • 11.10.2 Hologic, Inc. Business Overview
  • 11.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Introduction
  • 11.10.4 Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
  • 11.10.5 Hologic, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer